Table 2.
Characteristics of patients in the study and control groups.
| Characteristics | Study group n=50 | Control group n=50 | p value |
|---|---|---|---|
| Age (years) | 36.2 ± 5.3 | 35.4 ± 6.0 | 0.50∗ |
| Males, n (%) | 39/11 | 43/7 | 0.30∗ |
| BCVA, logmar | −0.006 ± 0.02 | −0.008 ± 0.02 | 0.69∗ |
| IOP (mmHg) | 16.1 ± 2.2 | 15.9 ± 1.9 | 0.86∗∗ |
| Axial length (mm) | 22.4 ± 0.7 | 22.7 ± 0.6 | 0.20∗∗ |
| Spherical equivalent (dpt) | −0.35 ± 0.89 | −0.33 ± 0.63 | 0.52∗ |
| Exophthalmometry (mm) | 18.7 ± 2.2 | 17.4 ± 0.9 | 0.002∗ |
| BMI | 24.2 ± 1.9 | 24.3 ± 1.6 | 0.69∗∗ |
| MBP (mmHg) | 88.9 ± 4.3 | 88.3 ± 4.7 | 0.53∗∗ |
| Disease duration (years) | 3.1 ± 1.7 | N/A | — |
| VISA inflammatory score | 4.7 ± 1.3 | N/A | — |
BCVA = best corrected visual acuity; logMar = logaritm of the minimum angle of resolution; IOP = intraocular pressure; BMI = body mass index; MBP = mean blood pressure; N/A = not applicable; ∗Mann–Whitney U test; and ∗∗Independent samples t-test.